
IBRO Neuroscience Reports, Journal Year: 2024, Volume and Issue: 16, P. 622 - 628
Published: May 22, 2024
Language: Английский
IBRO Neuroscience Reports, Journal Year: 2024, Volume and Issue: 16, P. 622 - 628
Published: May 22, 2024
Language: Английский
Nature, Journal Year: 2023, Volume and Issue: 622(7981), P. 130 - 138
Published: Sept. 20, 2023
Abstract Deep brain stimulation (DBS) of the subcallosal cingulate (SCC) can provide long-term symptom relief for treatment-resistant depression (TRD) 1 . However, achieving stable recovery is unpredictable 2 , typically requiring trial-and-error adjustments due to individual trajectories and subjective reporting 3 We currently lack objective brain-based biomarkers guide clinical decisions by distinguishing natural transient mood fluctuations from situations intervention. To address this gap, we used a new device enabling electrophysiology recording deliver SCC DBS ten TRD participants (ClinicalTrials.gov identifier NCT01984710). At study endpoint 24 weeks, 90% demonstrated robust response, 70% achieved remission. Using local field potentials available six participants, deployed an explainable artificial intelligence approach identify potential changes indicating patient’s current state. This biomarker distinct effects, sensitive therapeutic accurate at capturing states. Variable are predicted degree preoperative damage structural integrity functional connectivity within targeted white matter treatment network, matched facial expression detected using data-driven video analysis. Our results demonstrate utility in management personalized insight into relationship between multifaceted (functional, anatomical behavioural) features pathology, motivating further research causes variability treatment.
Language: Английский
Citations
121Annual Review of Neuroscience, Journal Year: 2023, Volume and Issue: 46(1), P. 341 - 358
Published: April 5, 2023
The field of stereotactic neurosurgery developed more than 70 years ago to address a therapy gap for patients with severe psychiatric disorders. In the decades since, it has matured tremendously, benefiting from advances in clinical and basic sciences. Deep brain stimulation (DBS) severe, treatment-resistant disorders is currently poised transition stage empiricism one increasingly rooted scientific discovery. Current drivers this are neuroimaging, but rapidly emerging ones neurophysiological—as we understand about neural basis these disorders, will successfully be able use interventions such as invasive restore dysfunctional circuits health. Paralleling steady increase consistency quality outcome data. Here, focus on obsessive-compulsive disorder depression, two topics that have received most attention terms trial volume effort.
Language: Английский
Citations
35Frontiers in Human Neuroscience, Journal Year: 2024, Volume and Issue: 18
Published: Feb. 21, 2024
The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9–11, 2023 in Gainesville, Florida with the theme of “Pushing Forefront Neuromodulation”. keynote speaker Dr. Nico Dosenbach from Washington University St. Louis, Missouri. He presented his research recently published Nature inn a collaboration Evan Gordon to identify and characterize somato-cognitive action network (SCAN), which has redefined motor homunculus led new hypotheses about integrative networks underpinning therapeutic DBS. DBS founded 2012 provides an open platform where clinicians, engineers, researchers (from industry academia) can freely discuss current emerging technologies, as well logistical ethical issues facing field. group estimated that globally more than 263,000 devices have been implanted for neurological neuropsychiatric disorders. This year's meeting focused advances following areas: cutting-edge translational neuromodulation, physiology, neuromodulation Europe Asia, neuroethical dilemmas, artificial intelligence computational modeling, time scales mood disorders, future devices.
Language: Английский
Citations
9Frontiers in Computational Neuroscience, Journal Year: 2023, Volume and Issue: 17
Published: March 6, 2023
Deep brain stimulation (DBS) is a promising therapy for treatment-resistant major depressive disorder (MDD). MDD involves the dysfunction of network that can exhibit complex nonlinear neural dynamics in multiple frequency bands. However, current open-loop and responsive DBS methods cannot track multiband MDD, leading to imprecise regulation symptoms, variable treatment effects among patients, high battery power consumption.Here, we develop closed-loop brain-computer interface (BCI) system predictive neuromodulation treating MDD. We first use biophysically plausible ventral anterior cingulate cortex (vACC)-dorsolateral prefrontal (dlPFC) mass model simulate response DBS. then offline identification build dynamic predicts effect on activity. next identified design an online BCI neuromodulation. The consists state estimator controller. estimates from history activity previously delivered patterns. controller takes estimated as feedback signal optimally adjusts regulate therapeutic targets. vACC-dlPFC simulation testbed test compare it with state-of-the-art treatments MDD.We demonstrate our accurately Consequently, regulates resulting significantly smaller control errors lower consumption than DBS.Our results have implications developing future precisely-tailored clinical
Language: Английский
Citations
14Nature Reviews Bioengineering, Journal Year: 2024, Volume and Issue: 2(8), P. 653 - 670
Published: June 3, 2024
Language: Английский
Citations
6Brain, Journal Year: 2024, Volume and Issue: 147(9), P. 3083 - 3098
Published: May 29, 2024
Abstract Comprehensive understanding of the neural circuits involving ventral tegmental area is essential for elucidating anatomofunctional mechanisms governing human behaviour, in addition to therapeutic and adverse effects deep brain stimulation neuropsychiatric diseases. Although has been targeted successfully with different diseases, axonal connectivity region not fully understood. Here, using fibre microdissections cadaveric hemispheres, population-based high-definition tractography previously reported hotspots, we find that participates an intricate network serotonergic pontine nuclei, basal ganglia, limbic system, forebrain prefrontal cortex, which implicated treatment obsessive–compulsive disorder, major depressive Alzheimer’s disease, cluster headaches aggressive behaviours.
Language: Английский
Citations
4Frontiers in Psychiatry, Journal Year: 2025, Volume and Issue: 16
Published: Jan. 30, 2025
Recent technological advances in intracranial brain stimulation have enhanced the potential of neuromodulation for addressing neuropsychiatric disorders. We present a review methodology and preliminary outcomes pioneering studies exploring biomarker detection closed-loop to modulate high-symptom severity states searched PubMed, Scopus, Web Science, Embase, PsycINFO/PsycNet, followed by reference citation lists retrieved articles. This search strategy yielded total 583 articles, which 5 articles met inclusion criteria, focusing on depression, obsessive-compulsive disorder, post-traumatic stress binge eating disorder. discuss identification, biomarkers identified, treatment neuromodulation. Successful identification hinges investigating across various setting. Targeted neuromodulation, either directed at or within its associated neural network, offers promising approach. Future research should seek understand mechanisms underlying effects as well long-term viability these different conditions.
Language: Английский
Citations
0Biological Psychiatry Cognitive Neuroscience and Neuroimaging, Journal Year: 2025, Volume and Issue: 10(2), P. 123 - 124
Published: Feb. 1, 2025
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown
Published: Sept. 20, 2023
Abstract Brain computer interfaces (BCI) provide unprecedented spatiotemporal precision that will enable significant expansion in how numerous brain disorders are treated. Decoding dynamic patient states from signals with machine learning is required to leverage this precision, but a standardized framework for identifying and advancing novel clinical BCI approaches does not exist. Here, we developed platform integrates signal decoding connectomics demonstrate its utility across 123 hours of invasively recorded data 73 neurosurgical patients treated movement disorders, depression epilepsy. First, introduce connectomics-informed decoders generalize cohorts Parkinson’s disease epilepsy the US, Europe China. Next, reveal network targets emotion left prefrontal cingulate circuits DBS major depression. Finally, showcase opportunities improve seizure detection responsive neurostimulation Our provides rapid, high-accuracy medicine can dynamically adapt neuromodulation therapies response individual needs patients.
Language: Английский
Citations
9Neurophotonics, Journal Year: 2024, Volume and Issue: 11(02)
Published: April 24, 2024
Early diagnosis of depression is crucial for effective treatment. Our study utilizes functional near-infrared spectroscopy (fNIRS) and machine learning to accurately classify mild severe depression, providing an objective auxiliary diagnostic tool mental health workers.
Language: Английский
Citations
3